Context Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$2.64(as of Apr 8, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Context Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$2.64
Ticker SymbolCNTX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees15
CountyUSA
Market Cap$240.7M

Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.

Context Therapeutics Inc In Our Stock Scanner

As of Apr 09, 2026
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
example chart graphic
Scan Name: Falling WedgeScan Type: Chart Pattern Scans
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.